Ozempic maker to cut thousands of jobs
1. Novo Nordisk plans to cut 9,000 jobs to streamline operations. 2. Job cuts aim to compete in the evolving diabetes and obesity market. 3. Eli Lilly is gaining market share with its weight-loss drugs. 4. Increased competition is affecting Novo Nordisk's profits and market presence. 5. Novo Nordisk will invest in science and manufacturing to enhance capabilities.